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ABSTRACT 
Preeclampsia is a severe pregnancy complication that has long been 
one of the leading causes of maternal and perinatal mortality and 
morbidity worldwide. Despite the achievements of modern medicine, 
the etiology of this pathology is not known. Multiple risk factors for the 
development of PE have been identified: arterial hypertension, 
diabetes mellitus, obesity, a hereditary history of preeclampsia, 
thrombophilia, etc., but recently, special attention has been paid to 
genetic determinants, namely, the contribution of individual 
polymorphic loci of various genes. In the course of our study, we 
studied the contribution of the rs5918 and rs1126643 polymorphisms 
of the GPIII and ITGA2 gene, respectively, associated with the 
development of hereditary thrombophilia, in the development of 
arterial hypertension, as one of the main symptoms of preeclampsia. 
The sample included 455 patients with PE; the average age of women 
was 26.41  4.92 years. It was found that women with PE with CC 
genotype of rs5918 polymorphism of the GPIIIa gene had a more 
pronounced increase in blood pressure indicators (the distribution of 
 
CC, CT, and TT genotypes was 2.25% (n=10), 25.68% (n=114), 
72.07% (n=320)), and with the TT genotype of polymorphism 
rs1126643 of the ITGA2 gene, a more pronounced increase in SBP 
and DBP was observed (the frequency of TT, CT genotypes is 19.06% 
(n=85), 48.43% (n=216), 32.51% (n=145 ) respectively). Thus, it was 
found that the CC rs5918 genotypes of the GPIII gene and TT 
rs1126643 of the ITGA2 gene are associated with a more pronounced 
increase in blood pressure in women with pre-eclampsia by the end of 
pregnancy. 
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thrombophilia, rs5918, rs1126643. 
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INTRODUCTION 
Preeclampsia (PE) is a pathological condition that develops 
in women during pregnancy (after 20 weeks) or a short time 
after childbirth, and is accompanied by the development of 
edema, proteinuria, hypertension, up to multiple 
organ/multisystem failure/ dysfunction. The global 
prevalence of PE is 3-6% and remains one of the main 
causes of maternal and perinatal mortality [Dymara-
Konopka et al., 2019].  
Despite the large number of studies on the etiology of PE, 
the leading cause of this disease remains unknown, like of 
most other diseases [Polonikov et al., 2017, Sirotina et al., 
2018, Yarosh et al., 2015]. Risk factors for PE include a 
family history of PE, diagnosed arterial hypertension before 
pregnancy, type 1 or type 2 diabetes, overweight (high body 
mass index), infections and excessive weight gain during 
pregnancy, chronic kidney disease, and others [Clinical 
recommendations (treatment protocols) of the Russian 
Federation, 2016]. Recently, more attention has been paid to 
the study of molecular biomarkers of PE development, 
which can be detected even before the onset of clinical signs, 
which will prevent the development of this disease and 
significantly reduce the adverse effects on the mother and 
fetus [Polonikov et al., 2015, Ponomarenko et al., 2019]. 
Thus, the catchiest as key links in the pathogenesis of PE are 
such molecular mechanisms as: immune maladaptation, 
endothelial dysfunction [Reshetnikov et al., 2019], 
thrombophilic disorders [Reshetnikov et al., 2017], 
angiogenic imbalance, dyslipidemia, etc. [Reshetnikov et al., 
2015]. Most of these mechanisms are based on genetic 
factors [Serebrova et al., 2018], which are responsible for the 
development of pathogenic changes [Agius et al., 2018]. The 
presence of hereditary forms of thrombophilia is associated 
with an increased risk of early development of PE [Mitriuc 
et al., 2019] and habitual miscarriage [Pritchard, Ashley M. 
et al., 2016].  
 
OBJECTIVE 
To assess the contribution of rs5918 and rs1126643 
polymorphisms of the GPIII and ITGA2 gene, respectively, 
associated with the development of hereditary 
thrombophilia, in the development of arterial hypertension 
in women with preeclampsia. 
 
MATERIAL AND METHODS 
The sample consists of 455 patients with PE. The average 
age of women was 26.41  4.92 years. All women are 
residents of the Central Black Earth Region of the Russian 
Federation and have no kinship. All women were measured 
their blood pressure, both before pregnancy and at the time 
of delivery. These polymorphic rs5918 loci of the GPIII gene 
and rs1126643 of the ITGA2 gene were selected for research 
based on the available data on their involvement in the 
hemostatic system [Fedorova et al., 2019], as well as in 
accordance with their significant regulatory potential 
(HaploReg v4.1). Processing of statistical data was 
performed using STATISTICA for Windows v. 8.0 (StatSoft, 
USA). 
 
RESULTS AND DISCUSSION 
The frequency of the CC, CT, and TT genotypes of the 
polymorphic rs5918 locus of GPIII gene among women with 
PE was 2.25% (n=10), 25.68% (n=114), 72.07% (n=320), and 
the frequency of the TT, CT, and CC of rs1126643 
polymorphism of the ITGA2 gene was 19.06% (n=85), 
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48.43% (n=216), 32.51% (n=145), respectively. Women with 
PE with the CC genotype of polymorphism rs5918 of the 
GPIIIa gene had a more pronounced increase in blood 
pressure indicators (SBP, DBP, MAP, PBP) by the end of 
pregnancy. It was also found that women with PE with the 
TT genotype of rs1126643 polymorphism of the ITGA2 gene 
had a more pronounced increase during pregnancy for SBP 
and DBP (Table). 
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Table 1: Association of polymorphisms of hereditary thrombophilia GPIIIa and ITGA2 genes with blood pressure values in women with preeclampsia. 
Values of blood pressure 
Genotypes 
rs5918 GPIIIa rs1126643 ITGA2  
   TT (n=85) CT (n=216) CC (n=145) 
SBP,  
mm Hg 
Before pregnancy 
During pregnancy 
Friedman ANOVA test, p 
110 (110-120) 
130 (110-140) 
0.0001 
110 (110-120) 
130 (110-140) 
0.0001 
110 (105 -115) 
140 (130 -150) 
0.0001 
110 (110-120) 
130 (120-140) 
0.0001 
110 (110-120) 
130 (110-140) 
0.0001 
110 (110-120) 
125 (110-140) 
0.0001 
DBP,  
mm Hg 
Before pregnancy 
During pregnancy 
Friedman ANOVA test, p 
70 (70-80) 
80 (70-80) 
0.0001 
70 (70-80) 
80 (80-90) 
0.0001 
70 (70-80) 
80 (80-100) 
0.0001 
70 (70-80) 
80 (80-90) 
0.0001 
70 (70-80) 
80 (70-90) 
0.0001 
70 (70-80) 
80 (70-90) 
0.0001 
PBP, 
 mm Hg 
Before pregnancy 
During pregnancy 
Friedman ANOVA test, p 
40 (40-40) 
40 (40-50) 
0.0001 
40 (40-40) 
42.5 (40-50) 
0.0001 
40 (40-40) 
60 (50-60) 
0.0001 
40 (40-40) 
40 (40-50) 
0.0001 
40 (40-40) 
40 (40-50) 
0.0001 
40 (40-40) 
40 (40-50) 
0.0001 
MAP,  
mm Hg 
Before pregnancy 
During pregnancy 
Friedman ANOVA test, p 
83.3 (83.3-86.6) 
96.6 (83.3-106.6) 
0.0001 
83.3 (83.3-83.3) 
100 (93.3-106.6) 
0.0001 
83.3 (83.3-83.3) 
100 (93.3-116.6) 
0.0001 
83.3(83.3-93.3) 
103.3(83.3-106.6) 
0.0001 
83.3 (83.3-85.0) 
96.6 (83.3-106.6) 
0.0001 
83.3(83.3-86.6) 
95.0 (83.3-103.3) 
0.0001 
Notes: DBP: diastolic blood pressure; MAP: mean arterial pressure; PBP: pulse blood pressure; SBP: systolic blood pressure; ANOVA: analysis of variance; p: value for the Mann-Whitney test. The values 
of blood pressure level are expressed a median (Me) and interquartile range (Q25  Q 75). 
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Many obstetrician-gynecologists regard the presence of 
hereditary thrombophilia as a risk factor for PE. A sufficient 
number of studies have been conducted to study the 
relationship between the Leiden mutation, prothrombin 
mutation, protein S deficiency, MTHFR C677T and others 
with late pregnancy complications [Rudzevich et al., 2018]. 
However, the effect of other mutations leading to a 
dysfunction in the hemostatic system on the development of 
PE has not been studied.  
We established that the CC genotype of the rs5918 
polymorphic locus of the GPIIIa gene is associated with a 
more pronounced dynamics of blood pressure during 
pregnancy. According to the literature, the genetic 
polymorphism rs5918 of the platelet fibrinogen receptor 
GPIIIa gene has a significant effect on platelet activity of 
hemostasis. The GpIIb/IIIa complex is expressed by 
platelets, which main ligand is fibrinogen. The replacement 
of thymine with cytosine in exon 2 of the GPIIIa gene at 
position 1565 leads to a replacement in the amino acid 
sequence of the GPIIIa glycoprotein leucine with proline at 
position 33, which affects the aggregation properties of 
platelets due to the conformational change in the N-
terminal disulfide loop involved in the binding of fibrinogen 
[Shikhbabaeva et al., 2017].   
It was also found that the TT genotype of rs1126643 
polymorphism of the ITGA2 gene is associated with a more 
pronounced course of SBP and DBP parameters. According 
to published data, the genetic rs1126643 polymorphism of 
integrin alpha-2ITGA2 encoding glycoprotein Ia - one of the 
components of the blood coagulation system, also affects the 
thrombotic link of hemostasis. This protein, together with 
glycoprotein IIa, forms the receptor complex, which is 
responsible for the interaction of platelets that express it on 
their surface with the collagen of the vessel wall, which leads 
to platelet aggregation and the formation of a thrombus. 
Replacing the cytosine nucleotide with thymine at position 
807 in the coding region of the gene, which does not lead to 
the replacement of the amino acid in the protein, can lead to 
an increase in the density of receptors on the platelet 
surface, which will increase the aggregation activity of 
platelets [Strambovskaya et al., 2014]. 
 
CONCLUSION 
It was found that the CC rs5918 genotypes of the GPIII gene 
and TT rs1126643 of the ITGA2 gene are associated with a 
more pronounced increase in blood pressure (SBP, DBP, 
MAP, PBP) in women with pre-eclampsia by the end of 
pregnancy (Friedman ANOVA test, p0.0001). The 
frequency of the CC, CT, and TT genotypes of the rs5918 
polymorphism of the GPIIIa platelet fibrinogen receptor 
gene among women with PE (the average age of patients is 
26.41 4.92 years) was 2.25% (n=10), 25.68% (n=114), 
72.07% (n=320), and the frequency of TT, CT, and CC 
rs1126643 genotypes of the integrin alpha-2ITGA2 gene 
encoding the glycoprotein Ia is 19.06% (n=85), 48.43% 
(n=216), 32.51% (n=145), respectively.  
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